The present invention is directed to the use of a composition comprising
a) N-(5-chlorosalicyloyl)-8-aminocaprylic acid, wherein N-(5-chlorosalicyloyl)-8-aminocaprylic acid comprises at least about 96% by weight of the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid; and
b) salmon calcitonin, for the preparation of a medicament for orally administering salmon calcitonin to an animal.
本发明涉及一种组合物的使用,该组合物包括
a) N-(5-
氯代
水杨酰)-
8-氨基辛酸,其中 N-(5-
氯代
水杨酰)-
8-氨基辛酸包含至少约 96% 的 N-(5-
氯代
水杨酰)-
8-氨基辛酸二钠盐(按重量计);以及
b) 鲑鱼
降钙素,用于制备给动物口服鲑鱼
降钙素的药物。